Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04485988
NCT04485988
Unknown
Not Applicable

Influence of Beta Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction

Chongqing Medical University1 site in 1 country3,000 target enrollmentJuly 1, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAMI
InterventionsBeta blocker
DrugsBeta blocker

Overview

Phase
Not Applicable
Intervention
Beta blocker
Conditions
AMI
Sponsor
Chongqing Medical University
Enrollment
3000
Locations
1
Primary Endpoint
Death
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

To understand the effect of beta blockers on the prognosis of patients with acute myocardial infarction with preserved ejection fraction.

Detailed Description

The use of beta blockers is an important component of drug therapy for myocardial infarction, but in some exceptional cases, evidence-based evidence for their use is insufficient, and we seek to understand the prognostic impact of beta blockers on patients enrolled in long-term follow-up.

Registry
clinicaltrials.gov
Start Date
July 1, 2015
End Date
July 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chongqing Medical University
Responsible Party
Principal Investigator
Principal Investigator

Dongying Zhang

Professor

Chongqing Medical University

Eligibility Criteria

Inclusion Criteria

  • •Patients with acute myocardial infarction

Exclusion Criteria

  • •Previous history of heart failure admission Killip class \> I class cancer pregnant

Arms & Interventions

beta blocker

Intervention: Beta blocker

Outcomes

Primary Outcomes

Death

Time Frame: The median time of 3 years

all-cause mortality

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
The Contemporary Role of Beta Blockers in Patients With Acute Myocardial InfarctionAcute Coronary Syndrome
NCT04564365Chongqing Medical University1,000
Unknown
Phase 3
Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or TrastuzumabBreast CancerCardiotoxicity
NCT02236806Azienda Ospedaliero-Universitaria Careggi262
Completed
Not Applicable
Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central ChinaAcute Coronary Syndrome
NCT03116854Henan Institute of Cardiovascular Epidemiology3,000
Unknown
Not Applicable
Effect of Preoperative Beta Blocker Use Postoperative Renal Function in the Patients Undergoing Liver TransplantationEnd Stage Liver DiseaseAcute Kidney Injury
NCT03633812Asan Medical Center477
Completed
Phase 4
Beta Blocker Therapy in Moderate to Severe COPDChronic Obstructive Pulmonary Disease
NCT01656005University of Dundee18